# LEVOTHYROXINE SODIUM
> **ANDA211369** · Abbreviated New Drug Application (Generic) · Sponsor: ANI PHARMS · Approved 2020-10-28
## Drug
- **FDA Application Number:** ANDA211369
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEVOTHYROXINE SODIUM
- **Generic name:** Levothyroxine Sodium
- **Active ingredients:** LEVOTHYROXINE SODIUM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ANI PHARMS
- **First approval:** 2020-10-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211369)
---
*MORVS · CC0 1.0*